Immune Landscape of Multiple Myeloma

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".

Deadline for manuscript submissions: 31 March 2026 | Viewed by 20

Special Issue Editors


E-Mail Website
Guest Editor
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA
Interests: multiple myeloma; stem cell transplant; amyloidosis; plasma cell disorders; CAR-T; bi/trispecific antibodies

E-Mail
Guest Editor
Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC 28204, USA
Interests: plasma cell disorders; multiple myeloma; amyloidosis; plasma cell leukemia; CAR-T
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Multiple myeloma (MM) is a hematologic malignancy characterized by the clonal proliferation of plasma cells within the bone marrow. While significant advances in therapeutic strategies have been made, including immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, the disease remains incurable for most patients, with eventual relapse and drug resistance. A growing body of evidence suggests that the immune microenvironment plays a pivotal role in MM pathogenesis, progression, and therapeutic response. The immune landscape of MM is marked by a complex interplay between malignant plasma cells and various immune cell subsets, including T cells, natural killer (NK) cells, dendritic cells, and myeloid-derived suppressor cells, many of which exhibit dysfunction or immunosuppressive phenotypes. Moreover, alterations in cytokine profiles and immune checkpoint expression contribute to immune evasion and tumor survival. Understanding the dynamic immune landscape of MM not only provides insights into disease biology but also opens avenues for novel immunotherapeutic strategies. Optimizing myeloma therapy in a thoughtful manner is crucial, particularly in the era of transformational T cell redirecting therapies (CAR T cell and bispecific antibodies), which are directly impacted by host T cell exhaustion and T cell dysfunction. This Special Issue explores the key components of the immune microenvironment in MM and their implications for disease progression and treatment optimization.

Dr. Muhamed Baljevic
Dr. Shebli Atrash
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • myeloma
  • immune
  • T cells
  • therapy
  • fitness

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop